7 headline mentions across 300+ news sites in the last 30 days.
Bars show how many headlines mentioned Summit Therapeutics on each day we took a news snapshot; the line shows their average tone.
Summit Therapeutics’ stock tumbles again as FDA recommends new trial for lung-cancer drug
marketwatch.com · Nov 17STAT Plus:FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics
statnews.com · Nov 17Plus 6 insider trading forms (Forms 3, 4, 5 and 144) in the last 90 days, not listed here.
Pulse Index alerts you when Summit Therapeutics files with the SEC, or is mentioned on the YouTube channels, news feeds and websites you follow.